Published in Acta Cardiol Sin on September 01, 2017
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med (1992) 20.79
The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA (1995) 9.54
Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59
The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med (1994) 8.10
The inflammatory response in myocardial infarction. Cardiovasc Res (2002) 7.92
The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med (1992) 6.41
EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J (2006) 4.57
ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation task force on Clinical Expert Consensus Documents. J Am Coll Cardiol (2012) 4.45
Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction. JAMA (2011) 3.44
Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl (2006) 2.84
Systemic inflammatory response syndrome. Br J Surg (1997) 2.70
Elevated levels of interleukin-6 in unstable angina. Circulation (1996) 2.66
The systemic inflammatory response syndrome in acute liver failure. Hepatology (2000) 2.47
Stress-activated cytokines and the heart: from adaptation to maladaptation. Annu Rev Physiol (2002) 1.92
Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation (1995) 1.66
Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats. Am J Physiol Heart Circ Physiol (2001) 1.60
Clinical implications of elevated serum interleukin-6, soluble CD40 ligand, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in patients with acute ST-segment elevation myocardial infarction. Clin Cardiol (2008) 1.54
The systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarction. Crit Care Med (2013) 1.52
Inflammation, sepsis, and coagulation. Haematologica (1999) 1.49
Systemic inflammatory response syndrome score at admission independently predicts mortality and length of stay in trauma patients. J Trauma (2000) 1.19
Third universal definition of myocardial infarction. Glob Heart (2012) 1.14
Disseminated intravascular coagulation. Thromb Haemost (1999) 1.12
Free radical and granulocyte-mediated injury during myocardial ischemia and reperfusion. Am J Cardiol (1989) 1.02
Relationship of systemic inflammatory response syndrome to organ dysfunction, length of stay, and mortality in critical surgical illness: effect of intensive care unit resuscitation. Arch Surg (1999) 0.99
The systemic inflammatory response syndrome, organ failure, and mortality after abdominal aortic aneurysm repair. J Vasc Surg (2003) 0.98
Inflammatory cytokines in atherosclerosis: current therapeutic approaches. Eur Heart J (2016) 0.93
Molecular evidence for induction of intracellular adhesion molecule-1 in the viable border zone associated with ischemia-reperfusion injury of the dog heart. Circulation (1994) 0.92
TSOC-HFrEF Registry: A Registry of Hospitalized Patients with Decompensated Systolic Heart Failure: Description of Population and Management. Acta Cardiol Sin (2016) 0.89
Acute phase reaction, infarct size and in-hospital morbidity in myocardial infarction patients treated with streptokinase or recombinant tissue type plasminogen activator. Ann Med (1991) 0.89
Cytokines: triggers of clinical thrombotic disease. Thromb Haemost (1997) 0.84
Role of myeloperoxidase as predictor of systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention. Am J Cardiol (2009) 0.81
Response of anticoagulant pathways in disseminated intravascular coagulation. Semin Thromb Hemost (2001) 0.80
Systemic Inflammatory Response Syndrome Predicts Mortality in Acute Coronary Syndrome without Congestive Heart Failure. West J Emerg Med (2010) 0.79
IL-6 and IL-1 receptor antagonist in stable angina pectoris and relation of IL-6 to clinical findings in acute myocardial infarction. J Intern Med (2000) 0.79
Interleukins 6 and 8 as mediators of acute phase response in acute myocardial infarction. Am J Cardiol (1997) 0.78
Association of Neutrophil-to-Lymphocyte Ratio with the Severity and Morphology of Coronary Atherosclerotic Plaques Detected by Multidetector Computerized Tomography. Acta Cardiol Sin (2016) 0.77
[Systemic inflammatory response syndrome: incidence and influence on outcome in acute myocardial infarction treated with primary angioplasty]. Med Intensiva (2007) 0.77
Predictive Value of Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio in Patients with Coronary Slow Flow. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2016) 0.75
Frequency of Vascular Inflammation and Impact on Neointimal Proliferation of Drug Eluting Stents in Porcine Coronary Arteries. Acta Cardiol Sin (2016) 0.75